A case of acute myeloid leukemia with e6a2 BCR-ABL fusion transcript acquired after progressing from chronic myelomonocytic leukemia Journal Article


Authors: Yao, J.; Douer, D.; Wang, L.; Arcila, M. E.; Nafa, K.; Chiu, A.
Article Title: A case of acute myeloid leukemia with e6a2 BCR-ABL fusion transcript acquired after progressing from chronic myelomonocytic leukemia
Abstract: Philadelphia (Ph) chromosome is a cytogenetic hallmark of chronic myeloid leukemia (CML). Most patients with CML harbor either the e13a2 or e14a2 BCR-ABL fusion product, while a small subset of the cases expresses e1a2 or e19a2 transcripts. We report a patient with chronic myelomonocytic leukemia (CMML), initially Ph chromosome negative at presentation, with rapid disease progression to acute myeloid leukemia (AML) and appearance of Ph chromosome and BCR-ABL e6a2, a very uncommon fusion transcript. The AML was refractory to treatment with subsequent emergence and dominance of a Ph negative leukemic clone. The patient expired shortly after disease progression. © 2017 The Authors
Keywords: cmml; aml transformation; bcr-abl e6a2
Journal Title: Leukemia Research Reports
Volume: 7
ISSN: 2213-0489
Publisher: Elsevier Inc.  
Date Published: 2017-01-01
Start Page: 17
End Page: 19
Language: English
DOI: 10.1016/j.lrr.2017.01.003
PROVIDER: scopus
PMCID: PMC5328719
PUBMED: 28275539
DOI/URL:
Notes: Article -- Export Date: 3 April 2017 -- Source: Scopus
Altmetric
Citation Impact
MSK Authors
  1. Khedoudja Nafa
    236 Nafa
  2. Jinjuan Yao
    54 Yao
  3. Lu Wang
    147 Wang
  4. Maria Eugenia Arcila
    621 Arcila
  5. Dan Douer
    87 Douer